His clinical research focuses on the treatment of advanced stages of renal cell carcinoma (RCC), combining systemic therapy with surgery. He is principal investigator of the European Organisation for Research and Treatment of Cancer (EORTC) trial investigating immediate versus deferred cytoreductive nephrectomy in patients with metastatic RCC treated with sunitinib.